Suppr超能文献

内镜黏膜下剥离术结合经肛内镜显微手术治疗大型结直肠腺瘤

Hybrid resection of large colorectal adenomas combining EMR and FTRD.

机构信息

Department of Gastroenterology, Sana Klinikum Lichtenberg, Berlin, Germany.

出版信息

Scand J Gastroenterol. 2021 Aug;56(8):978-983. doi: 10.1080/00365521.2021.1933583. Epub 2021 Jun 2.

Abstract

BACKGROUND

The introduction of the full-thickness resection device (FTRD) allowed resection of difficult adenomas in the duodenum and colorectum with non-lifting. The main limitation of this endoscopic technique is the lesion size. We describe a hybrid approach combining endoscopic mucosal resection (EMR) and FTRD in a cohort of 17 patients to reduce tumor size and enable full-thickness resection.

METHODS

Retrospective analysis from data of 17 patients who underwent hybrid EMR-FTRD for large adenomas in the colorectum at our institution. Technical success, histological confirmation of margin-free resection and adverse advents were studied.

RESULTS

16 of 17 (94.1%) lesions could be resected macroscopically complete with confirmed full-thickness resection. Histological work-up of the full-thickness specimens showed free lateral margins in 13 patients (76.4%), unclear margins in two patients (11.8%) and positive margins in two patients (11.8%). There were no immediate perforation or major bleeding, however one patient showed a stenosis after resection in the follow-up endoscopy. Follow-up endoscopy was available in 12 patients. In two of 12 patients a recurrent adenoma was detected.

CONCLUSIONS

Hybrid EMR-EFTR in the colorectum seems to be a safe and effective technique for large non-lifting lesions with positive lifting signs in the margins. Further prospective evaluation of efficacy, safety and long-term outcome of this hybrid technique is necessary.

摘要

背景

全层切除术(FTRD)的引入允许在不提起的情况下切除十二指肠和结直肠中的困难腺瘤。这种内镜技术的主要限制是病变大小。我们描述了一种结合内镜黏膜切除术(EMR)和 FTRD 的混合方法,该方法可减少肿瘤大小并实现全层切除。

方法

回顾性分析了我院 17 例因大肠大腺瘤而行混合 EMR-FTRD 的患者的数据。研究了技术成功率、边缘无残留的组织学确认和不良事件。

结果

17 例病变中的 16 例(94.1%)可在宏观上完全切除,并证实全层切除。对全层标本的组织学检查显示,13 例(76.4%)患者的侧缘无残留,2 例(11.8%)患者的侧缘不清楚,2 例(11.8%)患者的侧缘阳性。无即时穿孔或大出血,但 1 例患者在随访内镜检查中出现切除后狭窄。12 例患者可进行随访内镜检查。在 12 例患者中的 2 例中发现了复发性腺瘤。

结论

混合 EMR-EFTR 在大肠中似乎是一种安全有效的技术,适用于有阳性提升迹象的大非提升病变。需要进一步前瞻性评估这种混合技术的疗效、安全性和长期结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验